MorphoSys AG | Mutual Funds
Mutual Funds that own MorphoSys AG
Schroder ISF - EURO Equity
1,324,347
4.16%
11,028
2.27%
05/31/2018
Templeton Foreign Fund
906,960
2.85%
0
1.59%
03/31/2018
Oppenheimer Global Opportunities Fund
900,000
2.83%
0
1.13%
03/31/2018
Vanguard International Growth Fund
664,989
2.09%
0
0.21%
06/30/2018
Oppenheimer International Small Company Fund
551,095
1.73%
107,673
0.62%
02/28/2018
Government Pension Fund - Global (The)
500,104
1.57%
-99,144
0.01%
12/31/2017
iShares TecDAX (DE)
473,058
1.49%
0
4.57%
09/07/2018
Vanguard Total International Stock Index Fund
445,257
1.4%
3,963
0.02%
07/31/2018
Delaware Healthcare Fund
424,000
1.33%
14,000
7.67%
03/31/2018
Invesco European Growth Fund
338,839
1.06%
0
2.74%
06/29/2018
| Address |
Semmelweisstraße 7
Planegg Bayern (Bavaria) 82152
Germany
|
|
Employees
|
- |
| Website |
http://www.morphosys.de |
| Updated |
07/08/2019 |
| MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. |
